Best Melatonin Supplements 2026

Dose: Start Low — Physiologically Lower Is Better

The single most important buying decision for melatonin is dose. US products routinely contain 5–10mg — doses 10–30x above what research identifies as physiologically appropriate. A landmark 2001 study by Zhdanova et al. in Clinical Pharmacology & Therapeutics found that 0.3mg (300mcg) and 1.0mg were equally effective for sleep onset; doses above 1mg did not produce proportionally better sleep outcomes but did cause significantly higher plasma levels and more next-morning sedation. Start with 0.3–0.5mg and titrate upward only if needed. Reserve doses of 3–10mg for jet lag, shift work, or situations where a stronger phase-shifting signal is needed.

Timing: More Important Than Dose

Melatonin's phase-shifting effects depend critically on when it is taken relative to your circadian clock, not just how much you take. For sleep onset insomnia (difficulty falling asleep at your desired bedtime), take melatonin 30–60 minutes before your target sleep time. For delayed sleep phase disorder (DSPD), where you naturally sleep late and wake late, take melatonin 5–6 hours before your habitual sleep time to advance your clock earlier. For jet lag traveling east, take melatonin at the destination's bedtime starting 2–3 days before travel. Melatonin taken at the wrong circadian time can delay rather than advance sleep — timing is everything.

Immediate-Release vs. Extended-Release

Standard immediate-release melatonin produces peak plasma levels within 60–90 minutes and clears within 4–6 hours — well-suited for sleep onset but less helpful for sleep maintenance (waking in the middle of the night). Extended-release formulations provide sustained low-level melatonin throughout the night, which may better support sleep continuity. Extended-release is particularly relevant for older adults (who often have blunted melatonin amplitude and impaired sleep maintenance) and for those with sleep maintenance insomnia as the primary complaint.

Third-Party Testing: Essential for Gummies and Combination Products

A 2023 study in the Journal of Clinical Sleep Medicine tested 25 commercially available melatonin gummy products and found that 88% contained amounts significantly different from label claims — some contained up to 347% of the labeled dose. This is a critical quality concern for a sleep aid taken by millions of people (including parents who give gummies to children). Always choose products with independent certification: NSF Certified, USP Verified, or Informed Sport provide batch-level testing that verifies actual melatonin content matches the label.

Sleep Onset Insomnia

The most robust clinical evidence for melatonin is in sleep onset insomnia — difficulty falling asleep at the desired bedtime. A 2013 Cochrane systematic review (Ferracioli-Oda et al.) analyzed 19 RCTs (1,683 participants) and found that melatonin significantly reduced sleep onset latency by a mean of 7.06 minutes (95% CI: 4.37–9.75 minutes), increased total sleep time by 8.25 minutes, and improved overall sleep quality. While these effects are modest compared to sedative-hypnotic medications, melatonin's favorable safety profile — no significant adverse effects, no dependence, no rebound insomnia on discontinuation — makes it a first-line option for mild-to-moderate sleep onset insomnia.

Research: Ferracioli-Oda et al. (2013), PLOS ONE; Brzezinski et al. (2005), Sleep Med Rev.

Jet Lag

Melatonin's most consistently demonstrated clinical benefit is in jet lag — the misalignment of the internal circadian clock with the external day-night cycle after rapid time-zone travel. A Cochrane review by Herxheimer and Petrie (2002) analyzed 10 randomized trials and found melatonin to be remarkably effective for jet lag, with 8 of 10 trials showing significant benefit. Doses of 0.5–5mg taken at bedtime at the destination (starting on the day of travel, or up to 3 days before when traveling more than 5 time zones east) produced clinically meaningful reductions in jet lag severity, sleep onset, and daytime fatigue. This remains the strongest and most replicated evidence base for melatonin supplementation.

Research: Herxheimer and Petrie (2002), Cochrane Database Syst Rev; Arendt et al. (1987), BMJ.

Delayed Sleep Phase Disorder (DSPD)

DSPD — the inability to fall asleep until very late (2–6am) and corresponding difficulty waking at conventional times — is among the most responsive conditions to melatonin therapy. Chronobiological research by the Lewy Lab and others has established that low-dose melatonin taken 5–7 hours before the habitual sleep time effectively advances the circadian phase. A randomized crossover trial by Mundey et al. (2005) in Sleep found that 0.3mg melatonin taken in the afternoon produced significant circadian phase advances in DSPD patients — more effectively than 3mg, because the lower dose avoids masking effects that can reduce phase-shifting efficacy. This counterintuitive finding reinforces the importance of using the lowest effective dose.

Research: Mundey et al. (2005), Sleep; Nagtegaal et al. (1998), J Sleep Res; Lewy et al. (2006), PNAS.

Melatonin and Aging

Endogenous melatonin production declines substantially with age — studies using dim light melatonin onset (DLMO) measurement show that adults over 60 produce approximately 50–70% less melatonin than young adults, with further declines continuing into advanced age. This melatonin insufficiency correlates with the fragmented, early-waking sleep pattern common in older adults. Extended-release melatonin formulations (0.5–2mg) have shown particular promise in older adults, with a 3-week RCT by Luthringer et al. (2009) in Current Medical Research and Opinion demonstrating significant improvements in quality of sleep, morning alertness, and quality of life in patients aged 55+. The European Medicines Agency has approved Circadin (2mg prolonged-release melatonin) for this indication.

Research: Luthringer et al. (2009), Curr Med Res Opin; Waldhauser et al. (1988), J Clin Endocrinol Metab.

Routine Sleep Onset Support

• Evidence-based dose: 0.3–1mg
• Timing: 30–60 minutes before target bedtime
• Duration: Use as needed; not habit-forming

Jet Lag (Eastward Travel)

• Dose: 0.5–5mg at destination bedtime
• Timing: Begin on day of travel; continue 2–4 nights at destination
• Note: Higher doses (3–5mg) may be more appropriate for east-bound travel across 5+ time zones

Delayed Sleep Phase Disorder

• Dose: 0.3–0.5mg (low dose for phase-shifting; higher doses may reduce efficacy)
• Timing: 5–6 hours before habitual sleep time (e.g., 6pm for someone who naturally sleeps at midnight)
• Duration: Weeks to months; combine with light therapy and sleep schedule discipline

Stacking Melatonin with Complementary Sleep Nutrients

Melatonin works best as part of a comprehensive sleep hygiene and nutrition approach. Pair it with magnesium glycinate (magnesium deficiency is associated with poor sleep quality and restless legs; glycinate form is well-tolerated and calming), L-theanine (promotes alpha-wave relaxation without sedation, helps quiet pre-sleep mental chatter), and good sleep hygiene (consistent sleep schedule, reduced blue light 2 hours before bed, cool bedroom temperature). For stress-driven sleep disruption, consider adding an ashwagandha supplement — KSM-66 ashwagandha has RCT evidence for reducing cortisol and improving sleep quality in adults with chronic stress.